Our team has a wealth of experience and expertise in the development of protein/peptide therapeutics and an in-depth understanding of the needs of the pharmaceutical industry when it comes to the development and manufacture of novel, effective and safe biologics. In addition, with our business acumen and experience of forming strategic alliances we are working to build effective partnerships to deliver biologics solutions:
Dr Sam Williams | Non-Exec Chairman
Sam has 20 years' experience in the biotechnology industry, both as a top-ranked equity analyst in the City and, subsequently, as an entrepreneur and chief executive. He is CEO of Istesso Limited, a London-based drug discovery company, Non-Executive Chairman of C4X Discovery Holdings plc and Head of Biotech at IP Group plc. He holds a PhD in molecular biology from Cambridge and a degree in biology from Oxford.